Search Results

1 - 10 of 11 items :

  • "haemophilia" x
  • Human Biology x
Clear All
Implantoprosthetic rehabilitation of a patient with severe form of hemophilia B: a case report

subcommittee of factor VIII and factor IX of the scientific and standarization committee of the International Society on Thrombosis and Haemostasis Thromb Haemost. 2001 85 560 [4] Lehmann-Kopydlowska M, Zawilska K. Dental guidelines in congenital hemophilia A and B. Czas Stomatol. 2010;63(6):345-357. Lehmann-Kopydlowska M Zawilska K. Dental guidelines in congenital hemophilia A and B Czas Stomatol. 2010 63 6 345 357 [5] Bjorkman S, Carlsson M, Berntop E. Pharmacokinetics of factor IX in patients with haemophilia B: Methodological aspects and physiological interpretation

Open access
Global clotting assays - monitoring the effect of by-passing agents in haemophilia patients with inhibitors

. Mancuso ME, Fasulo MR. Thrombin Generation Assay as a Laboratory Monitoring Tool during Bypassing Therapy in Patients with Hemophilia and Inhibitors. Semin Thromb Haemost. 2016;42:30-5. 7. Mancuso ME, Chantaragkul V, Clerici M. Low thrombin generation during major orthopedic surgery fails to predict bleeding risk in inhibitor patients treated with bypassing agents. Haemophilia. 2016;22(4):292-30. DOI: 10.1111/hae.12939 8. Turecek PL, Varadi K, Keil B, Negrier C, Berntorp E, Astermark J, et al. Factor VIII inhibitor-bypassing agents act by

Open access
Progressive arthropathy in the course of immune tolerance induction failure in a child with hemophilia A and FVIII inhibitor – a case report

children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties. Haemophilia 2017;23:654–59. 28574205 10.1111/hae.13264 Collins P Chalmers E Alamelu J et al First-line immune tolerance induction for children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties Haemophilia 2017 23 654 59 [2] Ananyeva NM, Lacroix-Esmazes S, Hauser CA. Inhibitors in hemophilia A: mechanisms of inhibitor

Open access
Prothrombotic risk mutations and polymorphisms in patients with hemophilia A – a preliminary study / Polimorfismele și mutațiile cu risc protrombotic la pacienții cu hemofilie A - studiu preliminar

References 1. van Dijk K, van der Bom JG, Fischer K, Grobbee DE, van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost. 2004 Aug;92(2):305-10. 2. Franchini M, Lippi G. Factor V Leiden and hemophilia. Thromb Res. 2010 Feb;125(2):119-23. DOI: 10.1016/j. thromres.2009.11.003 3. Sanna V, Zarrilli F, Nardiello P, D’Argenio V, Rocino A, Coppola A, et al. Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A

Open access
False-negative coagulation factor activity results due to the presence of antiphospholipid antibodies in a case of autoimmune hemolytic anemia

detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 2007;13:317-322. 10.1111/j.1365-2516.2007.01450.x Sahud MA Pratt KP Zhukov O Qu K Thompson AR. ELISA system for detection of immune responses to FVIII. a study of 246 samples and correlation with the Bethesda assay Haemophilia 2007 13 317 322 [12] Tiede A, Werwitzke S, Scharf RE: Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803-811. 10.1055/s-0034-1390004 Tiede A Werwitzke S Scharf

Open access
Pitfalls in hemostasis exploration, a case report of a girl with Henoch-Schönlein type vasculitis

References 1. Franchini M, Zaffanello M, Lippi G. Acquired hemophilia in pediatrics: a systematic review.Pediatr Blood Cancer. 2010 Oct; 55(4):606-11. 2. Jan Bain M, Leissinger C, Kruse-Jarres R. Acquired hemophilia A: emerging treatment options. J Blood Med. 2015 May; 6: 143-150. 3. C.Kallanagowdar, A.Chauhan, M.V.Puertolas, R.Warrier. Prevalence and Resolution of Lupus Anticoagulant in Children.Ochsner Journal 2016; 16:172-175. 4. D.Williams, Duncan C. MacIvor.Patient Is Clotting: What Do You

Open access
Terapia manualna po alloplastyce stawu kolanowego u pacjenta z artropatią hemofilową w przebiegu hemofilii A – studium przypadku

arthroplasty. Haemophilia 2011;17:999–1004. Viliani T Zambelan G Pandolfi C et al In‐patient rehabilitation in haemophilic subjects with total knee arthroplasty Haemophilia 2011 17 999 1004 [4] Stephensen D, Bladen M, McLaughlin P. Recent advances in musculoskeletal physiotherapy for haemophilia. Ther Adv Hematol 2018;9:227–37. 10.1177/2040620718784834 30181843 Stephensen D Bladen M McLaughlin P Recent advances in musculoskeletal physiotherapy for haemophilia Ther Adv Hematol 2018 9 227 37 [5] Jaworski JM, Zawojski A, Zdziarska J

Open access
The influence of hemodialysis on FibroTest parameters

. Petrauskiene V, Vaiciuniene R, Kuzminskis V, Ziginskiene E, Grazulis S, Jonaitiene E, et al. Associations of vascular calcification, calcium phosphate disturbances, FGF 23 and Matrix Gla protein with mortality of hemodialysis patients: one center cohort study. Rev Romana Med Lab. 2018;26(4):451-60. DOI:10.2478/rrlm-2018-0034. DOI: 10.2478/rrlm-2018-0034 49. Maor Y, Calès P, Bashari D, et al. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients. Haemophilia. 2007

Open access
Acquired von Willebrand disease: from theory to practice. A single center experience - three case reports

, Nathan DG Eds. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood 8th Ed. Elsevier Saunders, Philadelphia. 2015:1103-24. 23. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single centre cohort study. J Thromb Haemost. 2008;6(4):569-76. DOI: 10.1111/j.1538-7836.2008.02909.x 24. Manfredi E, van Zaane B, Gerdes V.E.A, Brandjes D.P.M, Squizzato A. Hypothyroidism and acquired von Willebrand’s syndrome: a systematic review. Haemophilia

Open access
What about microparticles? Perspectives and practical aspects

. Tissue factor microparticles and haemophilia. Thromb Res.2010; 125:S67-9 49. Dignat-George F, Feyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets. 2009 ; 20(3):225-6 50. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res 2011; 127:370-7 51. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J et al. Impact of pre

Open access